Trifluoroacetic acid → N-[(4'R)-2''-amino-2',2'-dimethyldispiro[cyclopropane-1,3'-chromene-4',4''-[1,3]oxazol]-6'-yl]-5-me thoxypyrazine-2-carboxamide

HRID 873772Notes

Reaction equation

HRID 873772 reaction equation
[CH3:1][O:2][C:3]1[N:4]=[CH:5][C:6]([C:9]([NH:11][C:12]2[CH:13]=[C:14]3[C@@:23]4([CH2:27][O:26][C:25]([NH:28]C(=O)OC(C)(C)C)=[N:24]4)[C:20]4([CH2:22][CH2:21]4)[C:19]([CH3:37])([CH3:36])[O:18][C:15]3=[CH:16][CH:17]=2)=[O:10])=[N:7][CH:8]=1.FC(F)(F)C(O)=O>C(Cl)(Cl)Cl>[NH2:28][C:25]1[O:26][CH2:27][C@@:23]2([C:14]3[C:15](=[CH:16][CH:17]=[C:12]([NH:11][C:9]([C:6]4[CH:5]=[N:4][C:3]([O:2][CH3:1])=[CH:8][N:7]=4)=[O:10])[CH:13]=3)[O:18][C:19]([CH3:36])([CH3:37])[C:20]32[CH2:21][CH2:22]3)[N:24]=1

Participants

4

Procedure

To a solution of tert-butyl [(4′R)-6′-{[(5-methoxypyrazin-2-yl)carbonyl]amino}-2′,2′-dimethyldispiro[cyclopropane-1,3′-chromene-4′,4″-[1,3]oxazol]-2″-yl]carbamate (13.75 g, 26.98 mmol) in chloroform (140 ml) was added trifluoroacetic acid (68 ml) in an ice-water bath, and the mixture was stirred at room temperature for 3 hours. The mixture was concentrated in vacuo, and the residue was purified by silica gel column chromatography (pre-column: NH-silica gel; main column: neutral silica gel, chloroform/methanol=100:0-10:1). To the purified product was added saturated aqueous sodium hydrogen carbonate and extracted with chloroform. The organic layer were washed with brine, dried over anhydrous sodium sulfate, filtered, and the filtrate was evaporated in vacuo. The residue was purified by silica gel column chromatography (pre-column: basic silica gel; main column: neutral silica gel, chloroform/methanol=100:0-10:1). The purified product was triturated with a mixture of hexane/ethyl acetate (4:1) (300 mL), and the mixture was stirred at 60° C. for 1 hour and room temperature for 4 days. The precipitate was collected, washed with mixture of hexane/ethyl acetate (4:1) (200 mL), and dried in vacuo at 50° C. to afford N-[(4′R)-2″-amino-2′,2′-dimethyldispiro[cyclopropane-1,3′-chromene-4′,4″-[1,3]oxazol]-6′-yl]-5-methoxypyrazine-2-carboxamide (8.38 g) as a crystal.

Workup

  1. concentrationThe mixture was concentrated in vacuo
  2. customthe residue was purified by silica gel column chromatography (pre-column: NH-silica gel; main column: neutral silica gel, chloroform/methanol=100:0-10:1)
  3. additionTo the purified product was added saturated aqueous sodium hydrogen carbonate
  4. extractionextracted with chloroform
  5. washThe organic layer were washed with brine
  6. dry with materialdried over anhydrous sodium sulfate
  7. filtrationfiltered
  8. customthe filtrate was evaporated in vacuo
  9. customThe residue was purified by silica gel column chromatography (pre-column: basic silica gel; main column: neutral silica gel, chloroform/methanol=100:0-10:1)
  10. customThe purified product was triturated with a mixture of hexane/ethyl acetate (4:1) (300 mL)
  11. stirringthe mixture was stirred at 60° C. for 1 hour and room temperature for 4 days
  12. customThe precipitate was collected
  13. washwashed with mixture of hexane/ethyl acetate (4:1) (200 mL)
  14. customdried in vacuo at 50° C.

Sources & evidence

ORD record
ord-9f4ebbb372b54e7dba78de973377acb2
Source dataset
uspto-grants-2015_03
Patent number
US08975415B2

Reaction notes

Loading…